FORCE improves the lives of the millions of individuals and families facing hereditary breast, ovarian, pancreatic, prostate, colorectal and endometrial cancers. Our community includes people with a BRCA, ATM, PALB2, CHEK2, PTEN or other inherited gene mutation and those diagnosed with Lynch syndrome. We accomplish this through our education, support, advocacy and research efforts.
We are dedicated to providing up-to-date, expert-reviewed information and resources that help people make informed medical decisions. Our strong, supportive community of peers and professionals ensures no one must face hereditary cancer alone. FORCE serves as a champion, unifying the community and advocating for awareness, access to care, and better treatment and prevention options.
Some Women With Breast Cancer Report Experiencing ‘Flat Denial’ From Surgeons Post-Mastectomy
October 11th 2021Although many women with breast cancer report being satisfied with their decision to forgo reconstruction after a mastectomy, some indicate a lack of support from their surgeon as well as limited information on their options.
Read More
Navigating the Ins and Outs of Implant Reconstruction After Breast Cancer Surgery
October 6th 2021Different breast implant options and potential complications may make the reconstruction process difficult to understand, but one expert discusses the importance of knowing what you want and hopefully avoiding postsurgical issues.
Read More
Here’s How Men With Bladder, Colorectal and Prostate Cancer Can Treat Sexual Dysfunction
October 5th 2021Treatments for bladder, colorectal and prostate cancer may cause sexual dysfunction in men. Here, an expert provides insight into how patients and survivors may improve their sexual health.
Read More
Integrative Medicine: Do Herbs, Diet and Other Approaches Affect Cancer Outcomes?
September 30th 2021A successful cancer treatment process includes more than just surgery, chemotherapy and other treatments: it involves keeping up your wellness from both a physical and mental standpoint, an expert says.
Read More
A Landmark Study Shows PALB2 Mutations Increase the Risk of Certain Cancers
September 10th 2021In the largest study of people with inherited PALB2 mutations to date, the gene was linked to increased lifetime risk of breast cancer in women and men, ovarian and pancreatic cancer but not prostate or colorectal cancer.
Read More
New guidance from the Food and Drug Administration recommends that the makers of breast implants include a black-box warning, a patient decision checklist and other information on product labels that will help protect them against a cancer and an autoimmune condition that can arise from use of the devices.
Read More